Literature DB >> 26835058

Current Evidence and Recommendations for Cardiac Resynchronisation Therapy.

Matthew J Dewhurst1, Nicholas J Linker2.   

Abstract

The number of people in Europe living with symptomatic heart failure is increasing. Since its advent in the 1990s, cardiac resynchronisation therapy (CRT) has proven beneficial in terms of morbidity and mortality in selected heart failure (HF) patient populations, when combined with optimal pharmacological therapy. We review the evidence for CRT and the populations of HF patients it is currently shown to benefit, and those in which more research needs to be performed.

Entities:  

Keywords:  Cardiac resynchronisation therapy; complex devices; guidelines; heart failure; recommendations

Year:  2014        PMID： 26835058      PMCID： PMC4711566          DOI： 10.15420/aer.2011.3.1.9

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN： 2050-3369


  72 in total

1.  Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.

Authors:  C Leclercq; S Walker; C Linde; J Clementy; A J Marshall; P Ritter; P Djiane; P Mabo; T Levy; F Gadler; C Bailleul; J-C Daubert
Journal:  Eur Heart J       Date:  2002-11       Impact factor: 29.983

2.  The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging.

Authors:  Zayd A Eldadah; Boaz Rosen; Ilan Hay; Thor Edvardsen; Vinod Jayam; Timm Dickfeld; Glenn R Meininger; Daniel P Judge; Joshua Hare; Joao B Lima; Hugh Calkins; Ronald D Berger
Journal:  Heart Rhythm       Date:  2006-04       Impact factor: 6.343

3.  Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Authors:  William T Abraham; James B Young; Angel R León; Stuart Adler; Alan J Bank; Shelley A Hall; Randy Lieberman; L Bing Liem; John B O'Connell; John S Schroeder; Kevin R Wheelan
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

4.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

5.  Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients.

Authors:  Rikke Esberg Kirkfeldt; Jens Brock Johansen; Ellen Aagaard Nohr; Mogens Moller; Per Arnsbo; Jens Cosedis Nielsen
Journal:  Heart Rhythm       Date:  2011-04-14       Impact factor: 6.343

6.  Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.

Authors:  Giovanni Morani; Maurizio Gasparini; Francesco Zanon; Edoardo Casali; Alfredo Spotti; Albino Reggiani; Emanuele Bertaglia; Francesco Solimene; Giulio Molon; Michele Accogli; Corrado Tommasi; Alessandro Paoletti Perini; Carmine Ciardiello; Luigi Padeletti
Journal:  Europace       Date:  2013-02-24       Impact factor: 5.214

7.  The relationship of QRS morphology and mechanical dyssynchrony to long-term outcome following cardiac resynchronization therapy.

Authors:  Hideyuki Hara; Olusegun A Oyenuga; Hidekazu Tanaka; Evan C Adelstein; Toshinari Onishi; Dennis M McNamara; David Schwartzman; Samir Saba; John Gorcsan
Journal:  Eur Heart J       Date:  2012-02-19       Impact factor: 29.983

8.  Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.

Authors:  Valérie Valls-Bertault; Marjaneh Fatemi; Martine Gilard; Pierre Yves Pennec; Yves Etienne; Jean-Jacques Blanc
Journal:  Europace       Date:  2004-09       Impact factor: 5.214

9.  Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK.

Authors:  P A Mehta; S W Dubrey; H F McIntyre; D M Walker; S M C Hardman; G C Sutton; T A McDonagh; Martin R Cowie
Journal:  Heart       Date:  2009-07-08       Impact factor: 5.994

10.  Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial.

Authors:  Matthew Richardson; Nick Freemantle; Melanie J Calvert; John G F Cleland; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2007-05-31       Impact factor: 29.983
View more
  1 in total

Review 1.  Usefulness of Biomarkers for Predicting Response to Cardiac Resynchronization Therapy.

Authors:  Mohammad H Asgardoon; Ali Vasheghani-Farahani; Alborz Sherafati
Journal:  Curr Cardiol Rev       Date:  2020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.